Current Surgical, a Washington, DC-based medtech company, raised $3.2m in seed funding.
The round was led by True Ventures, with participation from 1517 Fund and SciFounders.
The company intends to use the funds to accelerate growth, expand operations and its business reach.
Co-founded by Alireza (Al) Mashal, PhD, and Chris Wagner, PhD, Current Surgical is a preclinical-stage company enabling a type of hybrid therapies through the development of surgical tools to allow doctors to precisely treat currently untreatable solid tumors. Current Surgical gives doctors a precision guided needle that can accurately destroy tumors, without harming surrounding healthy tissue, anywhere in the body. Its smart surgical needle technology combines high resolution sensors and real-time image analysis into one tool, giving doctors precise control and feedback while destroying tumors. As a result, surgeons will be able to treat any solid tumor in any location.
FinSMEs
22/02/2023